EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSHCOG00000013859
Gene Symbol: ATP1B1
3 Cross references
224 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSHCOG00000005336
Gene Symbol: ATP1B2
3 Cross references
203 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSHCOG00000000593
Gene Symbol: ATP1B3
3 Cross references
236 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSHCOG00000018285
Gene Symbol: AXL
4 Cross references
187 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSHCOG00000009104
Gene Symbol: BRAF
3 Cross references
219 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSHCOG00000003635
Gene Symbol: BCL2
1 Cross references
175 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSHCOG00000003666
Gene Symbol: BCL2
1 Cross references
175 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSHCOG00000007622
Gene Symbol: BCL2L1
4 Cross references
226 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSHCOG00000014376
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSHCOG00000005647
Gene Symbol: BCR
3 Cross references
196 Possible Orthologues:

Bdnf/nt-3 Growth Factors Receptor-Like

Ensembl ID : ENSHCOG00000019902
Gene Symbol: LOC109527923
3 Cross references
207 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSHCOG00000007797
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).